A municipal health worker sprays insecticide to kill Aedes aegypti mosquitoes, which spread the Zika virus, in Campina Grande, Brazil.

A municipal health worker sprays insecticide to kill Aedes aegypti mosquitoes, which spread the Zika virus, in Campina Grande, Brazil. Felipe Dana / AP

Should Federal Agencies Stop Researching Drunk Birds to Fund the Zika Response?

Obama battles Congress for emergency funding as agencies prepare for outbreak.

For most Republicans in Congress, the debate over funding the research into and prevention of the spread of the Zika virus is a standard issue divide over federal spending, offsets and balanced budgets.

For Sen. Jeff Flake, R-Ariz., however, the clash playing out this week in both chambers represents something broader, and an opportunity to fix what he sees as a broken system. Flake has said there is not nearly enough oversight of how the federal science community spends its research dollars, arguing agencies like the National Institutes of Health would be better prepared to deal with emergencies like Zika if they were not wasting money on asinine studies.

“The White House has just asked Congress to appropriate $1.9 billion in emergency off-budget spending to tackle the latest crisis, Zika,” Flake said last week on the Senate floor. “Now I believe we do need to find a solution and a vaccine for the Zika virus, but we ought to look hard at the other things these agencies are spending money [on] as we talk about more money for these research projects.”

Flake unveiled during his speech his report “20 Questions: Government Studies That Will Leave You Scratching Your Head,” which highlights research the senator said does little to advance federal priorities. Studies such as where on the human body it hurts the most to get stung by a bee and whether birds slur while chirping after consuming alcohol -- supported by NIH and the National Science Foundation -- lead to agencies “wasting money” and “missing opportunities,” he said. All told, Flake identified $35 million disbursed on projects “that could have been better spent researching treatments for cancer, Alzheimer’s disease, and viral infections such as Zika and Ebola.”

Flake also introduced the Federal Research Transparency and Accountability Act, which the senator said would ensure research funding went toward “transformative science while rooting out unnecessary spending on lower priority projects.”

White House Press Secretary Josh Earnest said last week it was “pretty pathetic” for Flake to play politics with a national emergency, as the Republican lawmaker was usually “the kind of person [the administration] would rely on” to rise above the fray in dire situations. 

While Flake timed his report to highlight the issue in advance of the Zika spending fight, the $35 million he identified pales in comparison to the $1.9 billion the Obama administration requested in emergency appropriations in February. The White House said the funds would assist the Departments of Health and Human Services and State to prevent the spread of and respond to Zika, speed research and procurement of a vaccine and other medicines, provide emergency funds to territories such as Puerto Rico and boost foreign aid to Zika-affected countries.

Absent congressional action, federal agencies have been forced to reprogram existing funds -- such as the nearly $600 million from the emergency Ebola account -- to address the new crisis. The White House’s Earnest said on Monday this amounted to “essentially the bureaucratic equivalent of digging through the sofa cushions to try to come up with the necessary money.”

Congress appears unlikely to grant Obama’s entire wish list, with the Senate on Tuesday rejecting a proposal from Florida Sens. Bill Nelson, D, and Marco Rubio, R, to fund the full request. The upper chamber instead advanced a smaller, $1.1 billion agreement ironed out by Sens. Patty Murray, D-Wash, and Roy Blunt, R-Mo.

One major difference in the two bills is the Nelson-Rubio package fully replenishes the Ebola account, while the Blunt-Murray measure only pays back $88 million. Citing renewed outbreaks in West Africa, the Obama administration on Tuesday said the Ebola funds “must be replenished to keep the disease from threatening our shores again.”

The larger bill would have provided $743 million to the Centers for Disease Control and Prevention for boosting surveillance and state and local laboratory capacity, compared to $449 million included in the measure the Senate approved. It would have given $77 million more to NIH -- which is still researching the effects of Zika, in addition to developing treatments and a vaccine -- than the passed bill, and doubled the $126 million for U.S. territories. The Florida lawmakers proposed giving $10 million to the Food and Drug Administration, while the Senate ultimately approved no emergency funds for the agency. Their measure also would have provided more than $100 million on top of the Blunt-Murray bill for State and the U.S. Agency for International Development.

House Republicans, meanwhile, have blasted the White House for failing to provide more specifics on how exactly agencies would spend the emergency funds the administration requested. Without that information, the leadership and appropriators have said, Congress will be forced to wait until it passes fiscal 2017 spending bills to provide the funding -- meaning agencies like CDC, NIH and USAID would have to wait until October to see their new funds. 

In the interim, Republicans have put forward a $622 million bill using more money from the Ebola account and other existing HHS appropriations. The bill is about one-third of the administration’s request, with CDC taking the biggest hit. The agency would receive just $170 million under the House plan. House Appropriations Committee Chairman Hal Rogers, R-Ky., said lawmakers in his party have “made our own funding determinations, using what information is available and through discussions with federal agencies, to craft a proposal to fight the spread of this damaging disease.”

The White House quickly issued a veto threat on Tuesday, calling the House proposal “woefully inadequate.” It also criticized a mandate the money be spent only in fiscal 2016, as CDC has predicted the effects of the outbreak to ramp up in the summer months and be felt beyond September.

While the House is scheduled to take up its Zika bill as soon as Wednesday, the White House is not expecting lawmakers to address the situation any time soon in a way administration officials view as serious.

“Look, is it going to require the onset of that emergency before Republicans act?” Earnest asked on Monday. “I sure hope not, but that's the direction it seems to be trending.”

As for Flake, the senator crusading for strictly “transformative” scientific research? He was one of 29 senators voting against the emergency funding, saying the spending must be offset. 

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.